Hong Kong stocks closed higher Monday as investors bought shares at lower prices following several sessions of losses, while attention turned to upcoming Chinese economic data and a planned meeting between U.S. President Donald Trump and Chinese President Xi Jinping.
The Hang Seng Index rose 0.5%, or 116.24 points, to close at 23,753.84, while the Hang Seng China Enterprises Index gained 0.6%, or 44.01 points, to finish at 7,981.54.
Trump is expected to meet Xi and Russian President Vladimir Putin on the sidelines of the APEC forum in Shenzhen later this week. Discussions are expected to cover nuclear arms reduction and the U.S.-Israeli war with Iran.
In corporate developments, Innovent Biologics (HKG:1801) said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion on Zybrivo, or sintilimab, as a first-line treatment for advanced non-squamous non-small cell lung cancer. Shares of the company fell 1%.
GenFleet Therapeutics (Shanghai) (HKG:2595) said the first patients in China and Australia had received doses in a Phase Ib/II combination study of its oral Pan-RAS inhibitor GFH276 for pancreatic cancer. Shares fell nearly 11%.
Comments